
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Top Brokers
Investor discussions surrounding Journeo Plc (JNEO) during the specified period indicate a generally optimistic sentiment, despite some caution regarding the stock's performance. Participants expressed belief that the stock is currently undervalued, with one investor stating, "Yes, they should be very good. Over sold in my opinion," reflecting a conviction that the company's upcoming results may defy current market perceptions.
There is palpable anticipation for the forthcoming financial results, with another investor commenting, "Looking forward to results next week DYOR," suggesting that many are relying on this data to further guide their investment decisions. This indicates a level of confidence in the company’s fundamentals, and the discussions hint at a potential upward momentum in investor sentiment following the results announcement. Overall, the mood suggests that investors are hopeful for positive developments that could validate their belief in the stock's long-term value.
Show more
Journeo PLC has announced the upcoming release of its audited final results for the fiscal year ending December 31, 2024. The results are scheduled to be published on March 25, 2025, followed by a live presentation from CEO Russ Singleton and CFO Nick Lowe on March 26. The presentation will be accessible to both existing and potential shareholders through the Investor Meet Company platform, allowing investors to engage and submit questions prior to and during the event.
This announcement signifies a critical moment for Journeo PLC as it prepares to disclose its financial performance and strategic developments from the past year. This event could provide valuable insights into the company’s operational status and market position, especially as it continues to serve as a key provider of information systems and services within the transport sector.
Show more
Yes, they should be very good. |
Looking forward to results next week DYOR |
Perhaps some are worried about the weak trading from rail-focused businesses like Tracsis and Renew caused by the start of control period 7 and the change of government slowing down contract awards . However Journeo is much more bus focused and most importantly we have a very recent trading update where they upgraded expectations for FY25 . Management have always been very conservative with expectations here and repeatedly beat them , so to upgrade so early in the year when they would have already felt the effect of these headwinds is very reassuring . That makes the valuation, with the massive cash pile to factor in too , look insanely cheap for a company with very exciting growth prospects . These are once in a generation bargains on AIM right now |
Well someone is selling 10k gbp chunks aggressively today |
Looks like it is going to move up It has Gone to NT only Been some largish buys after hours this week |
Cavendish |
~ 11x earnings |
Good chance st tips this in his bargain shares if its out tomorrow |
Great write up in this substack I missed |
LinkedIn from the past few days |
JNEO only have 14.47m shares outstanding, if JNEO keep posting positive performance figures in the future IMHO the share price should keep rising. |
Yes, another nice order. |
RNS - £1.1m order. |
If you take the comments from Russ at the last presentation at face value then we're looking at 1 or 2 bolt-ons financed from internal resources early in 2025, followed by potentially something more substantial (requiring a placing) later in the year. |
Totally agree, Adam. The fact they were willing to upgrade in January, and also talked to strong order intake (which is a revenue figure, while Cavendish upped on profit margin), is a significant positive if you read between the lines. Hence my surprise the market did not cotton on and re-rate the stock. But therein lies the window of opportunity for me. |
Yes, I would much rather invest in a company which is understated with its guidance. Let investors take an excited view or not - the last thing I want is profit warnings |
Good point there Adam - nice start to the year. I for one am happy for mangement here to be pretty conservative. With the lumpy nature of their work too that makes all then more sense - it really gets my goat up that some companies over promise under deliver and make up sketchy excuses as to why they didnt hit targets. To be fair to a company like Journeo it must be tricky for them at start of the year to know how it will all pan out. |
Eric |
interestingly on stokopedia the company qualifies for 5 long screens (plus 1 short !) |
Some very quick maths. |
I've been buying after the trading update. I was a bit concerned over how FY25 would play out because it's a bit difficult to model but the confidence with which Russ has already upgraded FY25, and we're only in January is significantly reassuring to me. I am actually quite surprised the market has not put a higher multiple on this after the trading update and pushed the stock above 300p. As and when they deploy the cash which is more than 25% of the market cap... I think that will be a major catalyst for the stock, and it would not surprise me if we hear something around this within the next few months. |
4* |
Feels like there is risk to the upside and i am expecting a larger earnings beat this year before adding accretive bolt-ons. Plenty more upside here imo and one of the few sectors with macro tailwinds. |
Good update today, onward and upward. |
Type | Ordinary Share |
Share ISIN | GB00BKP51V79 |
Sector | Special Industry Machy, Nec |
Bid Price | 250.00 |
Offer Price | 255.00 |
Open | 250.00 |
Shares Traded | 39,045 |
Last Trade | 11:00:07 |
Low - High | 250.00 - 252.50 |
Turnover | 46.09M |
Profit | 2.97M |
EPS - Basic | 0.1752 |
PE Ratio | 14.41 |
Market Cap | 42.43M |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions